Evidence map›Paper›PMID 25503564›Full record

ArticleNature cell biology2015

Degradation of Cep68 and PCNT cleavage mediate Cep215 removal from the PCM to allow centriole separation, disengagement and licensing.

Julia K Pagan, Antonio Marzio, Mathew J K Jones, Anita Saraf, Prasad V Jallepalli, Laurence Florens, Michael P Washburn, Michele Pagano

Abstract read
In one paragraph

Article in Nature cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Atrial Fibrillation and Primary Cilia-Associated Genes: The Role of CEP68.International journal of molecular sciences · 2026
    Article
  8. Review
  9. Article
  10. SKP1-CUL1-F-box: Key molecular targets affecting disease progression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Homozygous mutation inJournal of medical genetics · 2022
    Article
  18. Review
  19. Triple deletion ofCell cycle (Georgetown, Tex.) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Julia K PaganDepartment of Pathology, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York 10065, USA.
Antonio MarzioDepartment of Pathology, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York 10065, USA.
Mathew J K JonesMolecular Biology Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue New York 10065, USA.
Anita SarafThe Stowers Institute of Medical Research, 1000 East 50th Street, Kansas City Missouri 64110, USA.
Prasad V JallepalliMolecular Biology Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue New York 10065, USA.
Laurence FlorensThe Stowers Institute of Medical Research, 1000 East 50th Street, Kansas City Missouri 64110, USA.
Michael P Washburn1] The Stowers Institute of Medical Research, 1000 East 50th Street, Kansas City Missouri 64110, USA [2] Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City Kansas 66160, USA.
Michele Pagano1] Department of Pathology, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York 10065, USA [2] Howard Hughes Medical Institute, 522 First Avenue New York 10016, USA.
Stowers Institute for Medical Research · USMemorial Sloan Kettering Cancer Center · USNew York University · USHoward Hughes Medical Institute · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
REGULATION OF THE GI PHASE BY THE UBIQUITIN PATHWAYR01GM057587 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 1998 to 2018
$7.8M
Regulation of Chromosome Segregation in Human CellsR01GM094972 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI JALLEPALLI, PRASAD V · 2010 to 2021
$5.3M
F-box proteins: deregulated cell cycle control and proteolysis in cancerR37CA076584 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 2006 to 2016
$4.7M
Acquisition of a DeltaVision OMX SR 3D SIM system for super-resolution imagingS10RR031855 · NCRR · ROCKEFELLER UNIVERSITY · PI NORTH, ALISON JANE · 2011 to 2011
$600k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA008748NCI NIH HHS R37 CA076584NCRR NIH HHS S10 RR031855NIGMS NIH HHS R01 GM057587NIGMS NIH HHS R01 GM094972
6 · The paper itself

Abstract

An intercentrosomal linker keeps a cell's two centrosomes joined together until it is dissolved at the onset of mitosis. A second connection keeps daughter centrioles engaged to their mothers until they lose their orthogonal arrangement at the end of mitosis. Centriole disengagement is required to license centrioles for duplication. We show that the intercentrosomal linker protein Cep68 is degraded in prometaphase through the SCF(βTrCP) (Skp1-Cul1-F-box protein) ubiquitin ligase complex. Cep68 degradation is initiated by PLK1 phosphorylation of Cep68 on Ser 332, allowing recognition by βTrCP. We also found that Cep68 forms a complex with Cep215 (also known as Cdk5Rap2) and PCNT (also known as pericentrin), two PCM (pericentriolar material) proteins involved in centriole engagement. Cep68 and PCNT bind to different pools of Cep215. We propose that Cep68 degradation allows Cep215 removal from the peripheral PCM preventing centriole separation following disengagement, whereas PCNT cleavage mediates Cep215 removal from the core of the PCM to inhibit centriole disengagement and duplication.

Indexed as

ProteolysisAntigensCell Cycle ProteinsCell Line, TumorCentriolesHEK293 CellsHeLa CellsHumansIntracellular Signaling Peptides and ProteinsMetaphaseMicrotubule-Associated ProteinsNerve Tissue ProteinsPhosphorylationPolo-Like Kinase 1PrometaphaseProtein BindingAntigensCDK5RAP2 protein, humanCell Cycle ProteinsCEP68 protein, humanIntracellular Signaling Peptides and ProteinsMicrotubule-Associated ProteinsNerve Tissue ProteinspericentrinPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsRNA, Small InterferingSKP Cullin F-Box Protein Ligases

Identifiers

PMID25503564
PMCPMC4415623
OpenAlexW2081051270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.